64x Bio launches LV Apex Suite, expanding its CellMap-Driven VectorSelect platform into lentiviral vector production June 30, 2026 Categories: Health Care Tags: 64x Bio
64x Bio launches AAV Apex Suite to power the next generation of gene therapy manufacturing June 16, 2025 Categories: Health Care Tags: 64x Bio
64x Bio raises $55 Million Series A financing to advance cell line engineering platform for gene therapy manufacturing January 20, 2022 Categories: Health Care Tags: 64x Bio
